Detalles de la búsqueda
1.
Histopathological growth patterns in patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study Group.
Br J Haematol
; 196(1): 99-104, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34396513
2.
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial.
Br J Haematol
; 196(1): 116-126, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34520052
3.
Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group.
Br J Haematol
; 193(3): 515-519, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33486762
4.
Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma.
Blood
; 132(21): 2273-2279, 2018 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30166329
5.
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Lancet
; 390(10114): 2790-2802, 2017 12 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29061295
6.
Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.
Blood
; 127(18): 2189-92, 2016 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26834240
7.
Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group.
Lancet Oncol
; 17(10): 1453-1462, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27612583
8.
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Lancet
; 385(9976): 1418-27, 2015 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25539730
9.
Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group.
Br J Haematol
; 171(4): 547-56, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26310520
10.
Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experience.
Blood
; 120(7): 1470-2, 2012 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-22786877
11.
Involved-Field Radiation Therapy Prevents Recurrences in the Early Stages of Hodgkin Lymphoma in PET-Negative Patients After ABVD Chemotherapy: Relapse Analysis of GHSG Phase 3 HD16 Trial.
Int J Radiat Oncol Biol Phys
; 111(4): 900-906, 2021 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34389407
12.
Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial.
Clin Cancer Res
; 27(2): 402-407, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33122344
13.
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial.
Lancet Haematol
; 8(6): e398-e409, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34048679
14.
The interplay between cancer-related fatigue and functional health in Hodgkin lymphoma survivors.
Health Psychol
; 39(10): 905-911, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32496079
15.
Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group.
J Clin Oncol
; 38(25): 2839-2848, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32574114
16.
Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial.
JAMA Oncol
; 6(6): 872-880, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32352505
17.
Suicide in European Hodgkin Lymphoma Patients.
Hemasphere
; 3(2): e183, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31723822
18.
Survivors' perspectives on risks and benefits of Hodgkin lymphoma treatment: results of a survey by the German Hodgkin Study Group.
Leuk Lymphoma
; 60(6): 1389-1398, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30507313
19.
Pretreatment Vitamin D Deficiency Is Associated With Impaired Progression-Free and Overall Survival in Hodgkin Lymphoma.
J Clin Oncol
; 37(36): 3528-3537, 2019 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31622132
20.
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group.
J Clin Oncol
; 37(31): 2835-2845, 2019 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31498753